Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein tyrosine kinase 2 (PTK2), commonly known as focal adhesion kinase (FAK), is a cytoplasmic non-receptor tyrosine kinase that plays a central role in integrating extracellular signals from integrins and growth factor receptors to regulate cell adhesion, migration, survival, and proliferation. FAK is highly overexpressed and activated in various solid tumors, including ovarian, pancreatic, and lung cancers, where it drives tumor progression, metastasis, and resistance to chemotherapy and targeted therapies. In May 2025, the FDA granted accelerated approval to the combination of the FAK inhibitor defactinib and the RAF/MEK inhibitor avutometinib for KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC), marking the first approved therapeutic regimen involving a FAK inhibitor. Beyond oncology, FAK is also implicated in fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and inflammatory conditions, making it a highly attractive therapeutic target. Therapeutic strategies targeting FAK include ATP-competitive small-molecule inhibitors, allosteric inhibitors, and proteolysis-targeting chimeras (PROTACs) designed to degrade the protein and block both its kinase and scaffolding functions.
Focal adhesion kinase inhibition and degradation
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein tyrosine kinase 2 (PTK2) (PTK2).